Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively
Knut Kölbel(Luther University), Elmar Wahle(Martin Luther University Halle-Wittenberg), Uwe Kühn(Max Planck Institute for Chemistry), Annette G. Beck‐Sickinger(Leipzig University), Christian Ihling(University of Stuttgart), Ines Neundorf(University of Cologne), Andrea Sinz(Martin Luther University Halle-Wittenberg), Kathrin Bellmann‐Sickert(Leipzig University)
Cited by 46
Related Papers
XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
|Pharmacological Reviews|1998|893
GPR39 Signaling Is Stimulated by Zinc Ions But Not by Obestatin
|Endocrinology|2006|432
Herbal drugs and phytopharmaceuticals
|Pharmaceutica Acta Helvetiae|1995|415
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226
|European Journal of Pharmacology|1994|374